Mirum Pharmaceuticals Inc
NASDAQ:MIRM

Watchlist Manager
Mirum Pharmaceuticals Inc Logo
Mirum Pharmaceuticals Inc
NASDAQ:MIRM
Watchlist
Price: 44.46 USD 2.25% Market Closed
Market Cap: 2.1B USD
Have any thoughts about
Mirum Pharmaceuticals Inc?
Write Note

Intrinsic Value

The intrinsic value of one MIRM stock under the Base Case scenario is 44.81 USD. Compared to the current market price of 44.46 USD, Mirum Pharmaceuticals Inc is Undervalued by 1%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MIRM Intrinsic Value
44.81 USD
Undervaluation 1%
Intrinsic Value
Price
Base Case Scenario

Valuation Backtest
Mirum Pharmaceuticals Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for MIRM cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about MIRM?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Mirum Pharmaceuticals Inc

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Mirum Pharmaceuticals Inc

Provide an overview of the primary business activities
of Mirum Pharmaceuticals Inc.

What unique competitive advantages
does Mirum Pharmaceuticals Inc hold over its rivals?

What risks and challenges
does Mirum Pharmaceuticals Inc face in the near future?

Has there been any significant insider trading activity
in Mirum Pharmaceuticals Inc recently?

Summarize the latest earnings call
of Mirum Pharmaceuticals Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Mirum Pharmaceuticals Inc.

Provide P/S
for Mirum Pharmaceuticals Inc.

Provide P/E
for Mirum Pharmaceuticals Inc.

Provide P/OCF
for Mirum Pharmaceuticals Inc.

Provide P/FCFE
for Mirum Pharmaceuticals Inc.

Provide P/B
for Mirum Pharmaceuticals Inc.

Provide EV/S
for Mirum Pharmaceuticals Inc.

Provide EV/GP
for Mirum Pharmaceuticals Inc.

Provide EV/EBITDA
for Mirum Pharmaceuticals Inc.

Provide EV/EBIT
for Mirum Pharmaceuticals Inc.

Provide EV/OCF
for Mirum Pharmaceuticals Inc.

Provide EV/FCFF
for Mirum Pharmaceuticals Inc.

Provide EV/IC
for Mirum Pharmaceuticals Inc.

Show me price targets
for Mirum Pharmaceuticals Inc made by professional analysts.

What are the Revenue projections
for Mirum Pharmaceuticals Inc?

How accurate were the past Revenue estimates
for Mirum Pharmaceuticals Inc?

What are the Net Income projections
for Mirum Pharmaceuticals Inc?

How accurate were the past Net Income estimates
for Mirum Pharmaceuticals Inc?

What are the EPS projections
for Mirum Pharmaceuticals Inc?

How accurate were the past EPS estimates
for Mirum Pharmaceuticals Inc?

What are the EBIT projections
for Mirum Pharmaceuticals Inc?

How accurate were the past EBIT estimates
for Mirum Pharmaceuticals Inc?

Compare the revenue forecasts
for Mirum Pharmaceuticals Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Mirum Pharmaceuticals Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Mirum Pharmaceuticals Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Mirum Pharmaceuticals Inc compared to its peers.

Compare the P/E ratios
of Mirum Pharmaceuticals Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Mirum Pharmaceuticals Inc with its peers.

Analyze the financial leverage
of Mirum Pharmaceuticals Inc compared to its main competitors.

Show all profitability ratios
for Mirum Pharmaceuticals Inc.

Provide ROE
for Mirum Pharmaceuticals Inc.

Provide ROA
for Mirum Pharmaceuticals Inc.

Provide ROIC
for Mirum Pharmaceuticals Inc.

Provide ROCE
for Mirum Pharmaceuticals Inc.

Provide Gross Margin
for Mirum Pharmaceuticals Inc.

Provide Operating Margin
for Mirum Pharmaceuticals Inc.

Provide Net Margin
for Mirum Pharmaceuticals Inc.

Provide FCF Margin
for Mirum Pharmaceuticals Inc.

Show all solvency ratios
for Mirum Pharmaceuticals Inc.

Provide D/E Ratio
for Mirum Pharmaceuticals Inc.

Provide D/A Ratio
for Mirum Pharmaceuticals Inc.

Provide Interest Coverage Ratio
for Mirum Pharmaceuticals Inc.

Provide Altman Z-Score Ratio
for Mirum Pharmaceuticals Inc.

Provide Quick Ratio
for Mirum Pharmaceuticals Inc.

Provide Current Ratio
for Mirum Pharmaceuticals Inc.

Provide Cash Ratio
for Mirum Pharmaceuticals Inc.

What is the historical Revenue growth
over the last 5 years for Mirum Pharmaceuticals Inc?

What is the historical Net Income growth
over the last 5 years for Mirum Pharmaceuticals Inc?

What is the current Free Cash Flow
of Mirum Pharmaceuticals Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Mirum Pharmaceuticals Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Mirum Pharmaceuticals Inc

Current Assets 386.6m
Cash & Short-Term Investments 284.4m
Receivables 68.5m
Other Current Assets 33.7m
Non-Current Assets 281.3m
Long-Term Investments 9.3m
PP&E 10.3m
Intangibles 255.8m
Other Non-Current Assets 5.8m
Current Liabilities 115.8m
Accounts Payable 9.5m
Accrued Liabilities 106.2m
Non-Current Liabilities 320.1m
Long-Term Debt 307.7m
Other Non-Current Liabilities 12.5m
Efficiency

Earnings Waterfall
Mirum Pharmaceuticals Inc

Revenue
307m USD
Cost of Revenue
-83.9m USD
Gross Profit
223.1m USD
Operating Expenses
-319.1m USD
Operating Income
-96m USD
Other Expenses
-3.8m USD
Net Income
-99.8m USD

Free Cash Flow Analysis
Mirum Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

MIRM Profitability Score
Profitability Due Diligence

Mirum Pharmaceuticals Inc's profitability score is 37/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
Exceptional Revenue Growth Forecast
Exceptional 1-Year Revenue Growth
37/100
Profitability
Score

Mirum Pharmaceuticals Inc's profitability score is 37/100. The higher the profitability score, the more profitable the company is.

MIRM Solvency Score
Solvency Due Diligence

Mirum Pharmaceuticals Inc's solvency score is 40/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Positive Net Debt
Average D/E
40/100
Solvency
Score

Mirum Pharmaceuticals Inc's solvency score is 40/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MIRM Price Targets Summary
Mirum Pharmaceuticals Inc

Wall Street analysts forecast MIRM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MIRM is 63.61 USD with a low forecast of 50.5 USD and a high forecast of 74.55 USD.

Lowest
Price Target
50.5 USD
14% Upside
Average
Price Target
63.61 USD
43% Upside
Highest
Price Target
74.55 USD
68% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for MIRM?

Click here to dive deeper.

Dividends

Mirum Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for MIRM is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

MIRM Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Mirum Pharmaceuticals Inc Logo
Mirum Pharmaceuticals Inc

Country

United States of America

Industry

Biotechnology

Market Cap

2.1B USD

Dividend Yield

0%

Description

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The company is headquartered in Foster City, California and currently employs 137 full-time employees. The company went IPO on 2019-07-18. The firm is focused on the identification, acquisition, development, and commercialization of therapies for rare and orphan diseases. The firm's main focus is the development and commercialization of LIVMARLI (maralixibat) oral solution (Livmarli) and Volixibat. Its pipeline consists of rare pediatric indications for Livmarli and orphan adult indications for its second product candidate, Volixibat. Livmarli is an oral solution as a once-daily medicine for cholestatic pruritus in patients with Alagille syndrome (ALGS) one year of age and older. Volixibat, is an oral, minimally absorbed agent designed to inhibit ileal bile acid transporter (IBAT), for the treatment of adult patients with cholestatic liver diseases. The firm is developing volixibat for the treatment of intrahepatic cholestasis of pregnancy (ICP), primary sclerosing cholangitis (PSC), and primary biliary cholangitis (PBC).

Contact

CALIFORNIA
Foster City
950 Tower Ln Ste 1050
+16506674085.0
mirumpharma.com

IPO

2019-07-18

Employees

137

Officers

CEO & Director
Mr. Christopher Peetz
COO & President
Mr. Peter Radovich M.B.A., Ph.D.
Chief Financial Officer
Mr. Eric H. Bjerkholt M.B.A.
Chief Scientific Officer
Dr. Pamela Vig Ph.D.
Vice President of Investor Relations and Finance
Andrew McKibben
Chief Compliance Officer
Mr. Paul K. Ross
Show More
Senior Vice President of Human Resources
Ms. Erin Campany
Chief Development Officer
Ms. Lara Longpre MBA, MSC
Senior vice President of Quality
Ms. Vinita P. Kumar
Senior Vice President of Technical Operations
Dr. Jean-Luc Girardet Ph.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one MIRM stock?

The intrinsic value of one MIRM stock under the Base Case scenario is 44.81 USD.

Is MIRM stock undervalued or overvalued?

Compared to the current market price of 44.46 USD, Mirum Pharmaceuticals Inc is Undervalued by 1%.

Back to Top